SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations

SARS-CoV-2 variants have continuously emerged in the face of effective vaccines. Reduced neutralization against variants raises questions as to whether other antibody functions are similarly compromised, or if they might compensate for lost neutralization activity. Here, the breadth and potency of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hederman, Andrew P., Natarajan, Harini, Heyndrickx, Leo, Ariën, Kevin K., Wiener, Joshua A., Wright, Peter F., Bloch, Evan M., Tobian, Aaron A. R., Redd, Andrew D., Blankson, Joel N., Rottenstreich, Amihai, Zarbiv, Gila, Wolf, Dana, Goetghebuer, Tessa, Marchant, Arnaud, Ackerman, Margaret E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449910/
https://www.ncbi.nlm.nih.gov/pubmed/37620337
http://dx.doi.org/10.1038/s41467-023-40960-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449910/
https://www.ncbi.nlm.nih.gov/pubmed/37620337
http://dx.doi.org/10.1038/s41467-023-40960-0

Ejemplares similares